NRAS and acute myeloid leukemia: To assess whether melanomas are uniquely sensitive to the synergistic effects of cardiac glycosides and MAPK pathway inhibitors we transplanted human NRAS mutant acute myeloid leukaemia cell lines (HL60 and U937) into NSG mice and monitored disease progression with bioluminescence imaging.